Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected children

H Simon Schaaf1, Sara Krook, Dete W Hollemans

  • 1Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africa.

Insights

Recurrent tuberculosis (TB) is common in children with human immunodeficiency virus (HIV). This study found that both TB relapse and reinfection occur in these vulnerable children.

Area of Science:

  • Pediatric infectious diseases
  • HIV/AIDS research
  • Tuberculosis epidemiology

Background:

  • Recurrent tuberculosis (TB) is more prevalent in adults with human immunodeficiency virus (HIV) compared to HIV-uninfected individuals.
  • Limited data exists on the recurrence patterns of TB specifically in pediatric populations.
  • Understanding TB recurrence in HIV-infected children is crucial for public health strategies.

Purpose of the Study:

  • To investigate the incidence and characteristics of recurrent TB in children diagnosed with culture-confirmed tuberculosis and HIV infection.
  • To differentiate between relapse and reinfection as causes of recurrent TB in this cohort.

Main Methods:

  • A cohort of HIV-infected children with culture-confirmed TB was followed from 1992 to 2004.
  • Recurrence was defined as a new TB episode occurring at least 6 months after completing prior therapy.
  • Restriction fragment length polymorphism (RFLP) analysis was used to compare Mycobacterium tuberculosis strains between episodes.

Main Results:

  • Nine out of 87 HIV-infected children experienced a second TB episode; two had a third episode.
  • Bacteriological cure was documented in 7 episodes prior to recurrence.
  • RFLP and epidemiological data indicated both relapse (same strain) and reinfection (different strain) contributed to recurrent TB.

Conclusions:

  • Recurrent tuberculosis is a significant concern in HIV-infected children within high TB burden settings.
  • Both endogenous relapse and exogenous reinfection are mechanisms driving recurrent TB in this population.
  • Further research is needed to optimize management and prevention strategies for TB in HIV-infected children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...